Kos Biotechnology Partners confirms third close of fund at $123m
Monday, June 15, 2026 · first reported by AltAssets
Kos Biotechnology Partners closes its first life sciences fund at $123M in its third closing, drawing from institutional investors and global family offices.
- Fund
- Kos Biotechnology Partners Fund I
- Size
- $123M
- Stage
- Interim close
- Asset class
- Venture
- Geography
- Global
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- DIG Ventures raises $120m third fund to target Europe’s AI infrastructure startupsAltAssets +1
- Sofia-based LAUNCHub Ventures secures €65 million first close of Fund III; targets €75 million+EU-Startups +4
- Stride Consumer grows fund 30% with $550m hard-cap close after four-month raiseAltAssets +1
- Forty.5 Ventures Closes a $30M First Fund to Move SEE Founders Onto the World StageThe Recursive
- SEC charges Meyer Global Management, CEO with defrauding investors in SpaceX pre-IPO fundPensions & Investments +1
- Two Google alumni raise $11.3M to back AI startups that enterprises will actually pay forTechCrunch +1